-+ 0.00%
-+ 0.00%
-+ 0.00%

IPO News | Shengsheng Cold Chain once again submitted to the Hong Kong Stock Exchange

Zhitongcaijing·07/22/2026 22:49:14
Listen to the news

Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on July 22, Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. (abbreviation: Shengsheng Cold Chain) submitted a listing application to the main board of the Hong Kong Stock Exchange, with CICC and Guojin Securities (Hong Kong) as co-sponsors. The company submitted its listing to the Hong Kong Stock Exchange on January 13, 2026. According to the prospectus, Shengsheng Cold Chain is a leading integrated temperature control supply chain service provider for the pharmaceutical and life science industry in China. The core focus is on clinical trial temperature control supply chain services, and also extends to temperature control supply chain services for commercial medical products, as well as R&D and manufacturing of temperature control equipment and materials. According to Frost & Sullivan, according to 2025 revenue, the company is the largest pharmaceutical and life science temperature control supply chain service provider in China, and the only Chinese company among the top ten clinical trial temperature control supply chain service providers in the world.

9788207a9054c217d95685986b42ede3.png